Page 1

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

DAILY EQUITY REPORT 12TH october 2018

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN FACE

INDIAN MARKET

CLOSE

PREVIOUS

! ASIAN MARKET CLOSE

PREVIOUS

NIKKEI

INDIAN EQUITY BENCHMARK:- At the close of market hours, the Sensex closed down 759.74 points or 2.19% at 34001.15, while the Nifty ended lower by 225.40 points or 2.15% at 10234.70. The market breadth is negative as 824 shares advanced, against a decline of 1,736 shares, while 866 shares were unchanged. Yes Bank, ONGC, HPCL and IOC were the top gainers, while State Bank of India, Tata Steel, Indiabulls Housing Finance

2129.67

and Bajaj Finserv lost the most

SECTORIAL INDICES CLOSE

CHANGE (%)

GLOBAL FACE

-2.12 8565.60

-2.09

4434.55

-3.07

5384.55

-2.14 -2.12

TOP GAINERS CLOSE 210

CHANGE (%) 16.21 5.77

IOC

278.25

BPCL

4.84 4.06

GAIL

!

!

Asian Market - Asian markets finished sharply lower today with shares in China leading the region. The Shanghai Composite is down 5.22% while Japan's Nikkei 225 is off 3.89% and Hong Kong's Hang Seng is lower by 3.60%. U.S. Market- Dow futures point to a 300-point drop as global stock markets continue to slide.

!

European markets - European markets are sharply lower today with shares in London off the most. The FTSE 100 is down 1.61% while France's CAC 40 is off 1.55% and Germany's DAX is lower by 1.20%.

TOP LOSERS CLOSE

CHANGE (%) -9.12

BAJAJFINSRV SBIN

5592

-6.20 -6.08 -4.99

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

MARKET MOVERS UPSIDE SCRIPT

CLOSE

HPCL

207.15 131

Daily Equity Report

NIFTY SPOT

STRATEGY

CHANGE (%) 14.70

PIVOT POINTS

5.39

S3

4.84

9831

S2

S1

10046 10152

4.69

IBULHSGFIN

R1

10367

SUPPORT S1-10152 S2-10046

NIFTY CLOSE

P

10261

R2

10476

R3

10691

RESISTANCE R1-10367 R2-10476

(%) -8.70 -8.10 -6.73

2235.15

-6.67

NET (CR.) 5976.88

7072.93

BANK NIFTY FUTURE BEARISH

5347.23

DII

NSE TOTALS

S3

23811

S2

24298

ADVANCE

S1

PIVOT POINTS P R1

24785

25061

R2

R3

25272

25759

RESISTANCE BANK NIFTY

9 BANK NIFTY

1

Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

MARKET TALKS

!

Yes Bank gains 3% ahead of CEO-search committee meet Shares of Yes Bank gained ~3% in the afternoon session Thursday ahead the first meeting of its CEO-search

!

committee scheduled later today to select the successor of current MD and CEO Rana Kapoor. On Friday, India’s fourth-largest private sector lender Yes Bank had appointed a search committee to decide Rana Kapoor’s successor. The bank’s aim was to shortlist three names to succeed the current managing director and chief executive officer of the bank. This will then be submitted to the country’s top bank RBI for its approval by Nov-end or the first week of December.

the company said in a press note on Wednesday after market hours.

!

OMC stocks gain on lower global crude oil prices Shares of oil marketing companies (OMCs) were trading up in the afternoon session on Thursday as Brent crude slipped below key levels of $83 per barrel. Shares of Hindustan Petroleum Corporation surged 11.50%, while those of Bharat Petroleum Corporation and Indian Oil Corporation were trading ~5% up, each.

Aurobindo USFDA approval for Azithromycin Oral Suspension Aurobindo Pharma received an approval from the US Food and Drug Administration (USFDA) for manufacturing and marketing Azithromycin Oral Suspension 100mg /5 mL and 200 mg/5 mL, the company said in a statement to the exchanges on Thursday.Azithromycin oral suspension is a generic version of Pfizer Inc’s Zithromax oral suspension. The company will launch this suspension in November 2018, the pharma major added.This oral suspension is used to treat patients with mild to moderate infections. The product has an estimated market size of $71mn for the twelve months ending August 2018, according to IQVIA.

!

PTC India signs deals for power supply to Bangladesh PTC India has inked fresh agreements for supplying 200MW power to Bangladesh for 15 years. Despite this, the company’s shares dropped 2% during the morning session on Thursday.The short-term power deal of 200MW is from a power pool of West Bengal State Electricity Distribution Company Ltd (WBSEDCL) and the long-term deal involves power to be supplied through imported coal from Meenakshi Energy Limited's imported coal-based project, .

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.

Capitalstars Financial Research Private Ltd., Reserves all Rights.

INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services: Intraday stock tips Financial advisory company Share market company

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME

NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE

Email:-backoffice@capiltalstars.in

Report Is Checked by Investment Advisor:

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

Daily equity reports 12 oct 2018  

CapitalStars Award Winning,SEBI registered investment advisory company.We provide intraday & positional services in equity,derivative ,c...

Daily equity reports 12 oct 2018  

CapitalStars Award Winning,SEBI registered investment advisory company.We provide intraday & positional services in equity,derivative ,c...

Advertisement